New data from clinical trials of arbaclofen and oxytocin underscore the murkiness of null results. Plus, researchers seek clarity on the neurodevelopmental effects of oxytocin during childbirth. SourceSource: Spectrum News

Autistic toddlers who receive a personalized intervention at about 18 months of age gain more abilities than those who start the therapy nine months later. SourceSource: Spectrum News

The new resource aims to aid reproducibility in imaging research. SourceSource: Spectrum News

Several studies caught researchers’ attention on social media this week, including one that compared gene expression in living versus postmortem samples of the human brain. SourceSource: Spectrum News

Here is a roundup of news and research for the week of 8 May. SourceSource: Spectrum News

The findings add to the growing evidence that genes with disparate functions can play similar roles in brain development. SourceSource: Spectrum News

The chimeric mouse model could provide a more realistic way to study microglia’s roles in brain conditions such as autism. SourceSource: Spectrum News

A shift in astrocyte secretions may explain the atypical firing patterns of neurons derived from people with fragile X syndrome. SourceSource: Spectrum News

The retracted studies mar hope for the drug’s use in depression. SourceSource: Spectrum News

This week we’re highlighting social-media chatter from the INSAR 2023 meeting in Stockholm, Sweden. SourceSource: Spectrum News

A growing proportion of researchers has reached such “super principal investigator” status, but the distribution is not even across demographic groups. SourceSource: Spectrum News

Compared with their non-autistic peers, young autistic girls have a thicker cortex that thins more quickly with age. SourceSource: Spectrum News

Autistic children taking the drug showed improvements in some behaviors but not in their social skills. SourceSource: Spectrum News

Here is a roundup of news and research for the week of 1 May. SourceSource: Spectrum News